Literature DB >> 21354519

Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma.

Ying-Hsu Chang1, Cheng-Keng Chuang, See-Tong Pang, Chun-Te Wu, Kun-Lung Chuang, Heng-Chang Chuang, Shuen-Kuei Liao.   

Abstract

Our objective was to assess the value of tumor necrosis and other factors for predicting the outcome of renal cell carcinoma (RCC). Our study comprised 328 RCC patients who were surgically treated at this hospital between 2001 and 2006. The five-year survival data was analyzed using a Kaplan-Meier statistical analysis. The prognostic factors were evaluated with a univariate analysis using a log-rank test and multivariate analysis using the Cox proportional hazards regression method. The mean follow-up period for these patients was 46.5 months (median 45.2 months). The univariate analysis revealed that age, tumor stage, TNM stage, grade, tumor necrosis, and histological type were statistically significant prognostic factors. The multivariate analysis showed that the TNM stage and tumor necrosis were the most important predictive factors in the patients' overall survival. In the TNM stage with and without tumor necrosis, the five-year overall survival rates in stages I+II were 80.5% and 89.2%, respectively (p=0.115), where as the five-year survival rates in stages III+IV were 32.7% and 84.0%, respectively (p<0.001). Collectively, our present data revealed that tumor necrosis was an important predictive factor for survival in advanced stage RCC. In conclusion, both the TNM stage and tumor necrosis provided the most important prognostic factors of survival in RCC. Tumor necrosis proved to be a poor prognostic factor in advanced RCCs.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21354519     DOI: 10.1016/j.kjms.2010.12.004

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  4 in total

Review 1.  Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.

Authors:  Amir H Khandani; W Kimryn Rathmell
Journal:  Semin Nucl Med       Date:  2012-07       Impact factor: 4.802

Review 2.  Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Lijin Zhang; Zhenlei Zha; Wei Qu; Hu Zhao; Jun Yuan; Yejun Feng; Bin Wu
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

3.  Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma.

Authors:  Sung Han Kim; Weon Seo Park; Sun Ho Kim; Ho Kyung Seo; Jae Young Joung; Kang Hyun Lee; Jinsoo Chung
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

4.  Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).

Authors:  Jinyan Wei; Jianhong Zhao; Xueling Zhang; Dan Wang; Wenjuan Zhang; Zhiping Wang; Junlin Zhou
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.